Beam Therapeutics Inc. beat EPS estimates 33% of the time across 3 reported quarters (1 beats, 2 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $1.00 | $-1.18 | -218.0% | Miss |
| Q12026 FY2026 | $-0.87 | $-0.91 | -4.6% | Miss |
| Q42025 FY2025 | $-1.13 | $-0.10 | +91.2% | Beat |
Back to BEAM overview · BEAM holders · BEAM KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.